Characteristics and outcomes of patients with COVID-19 at high-risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England
Vishal Patel, Marcus J. Yarwood, Bethany Levick, Daniel C. Gibbons, Myriam Drysdale, William Kerr, Jonathan D. Watkins, Sophie Young, Benjamin F. Pierce, Emily J. Lloyd, Helen J. Birch, Tahereh Kamalati, Stephen J. Brett
doi: https://doi.org/10.1101/2022.11.28.22282808
Vishal Patel
1GSK, Middlesex, UK
Marcus J. Yarwood
2Imperial College Health Partners, London, UK
Bethany Levick
3OPEN Health Evidence & Access, York, UK
Daniel C. Gibbons
1GSK, Middlesex, UK
Myriam Drysdale
1GSK, Middlesex, UK
William Kerr
1GSK, Middlesex, UK
Jonathan D. Watkins
2Imperial College Health Partners, London, UK
Sophie Young
2Imperial College Health Partners, London, UK
Benjamin F. Pierce
2Imperial College Health Partners, London, UK
Emily J. Lloyd
1GSK, Middlesex, UK
Helen J. Birch
1GSK, Middlesex, UK
Tahereh Kamalati
2Imperial College Health Partners, London, UK
Stephen J. Brett
4Department of Surgery and Cancer, Imperial College, London, UK
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
The Discover-NOW data that support the findings of this study are available from Imperial College Health Partners via approval from the Discover Data Access Group (DRAG) under certain restrictions.
Posted November 29, 2022.
Characteristics and outcomes of patients with COVID-19 at high-risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England
Vishal Patel, Marcus J. Yarwood, Bethany Levick, Daniel C. Gibbons, Myriam Drysdale, William Kerr, Jonathan D. Watkins, Sophie Young, Benjamin F. Pierce, Emily J. Lloyd, Helen J. Birch, Tahereh Kamalati, Stephen J. Brett
medRxiv 2022.11.28.22282808; doi: https://doi.org/10.1101/2022.11.28.22282808
Characteristics and outcomes of patients with COVID-19 at high-risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England
Vishal Patel, Marcus J. Yarwood, Bethany Levick, Daniel C. Gibbons, Myriam Drysdale, William Kerr, Jonathan D. Watkins, Sophie Young, Benjamin F. Pierce, Emily J. Lloyd, Helen J. Birch, Tahereh Kamalati, Stephen J. Brett
medRxiv 2022.11.28.22282808; doi: https://doi.org/10.1101/2022.11.28.22282808
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (669)
- Anesthesia (181)
- Cardiovascular Medicine (2650)
- Dermatology (223)
- Emergency Medicine (400)
- Epidemiology (12234)
- Forensic Medicine (10)
- Gastroenterology (760)
- Genetic and Genomic Medicine (4109)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2661)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3890)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (585)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6536)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (343)
- Surgery (450)
- Toxicology (53)
- Transplantation (185)
- Urology (166)